Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1956 1
1957 1
1970 1
1972 2
1973 16
1974 10
1975 4
1976 6
1977 20
1978 16
1979 6
1980 9
1981 7
1982 8
1983 14
1984 10
1985 9
1986 13
1987 7
1988 14
1989 14
1990 21
1991 6
1992 8
1993 6
1994 5
1995 4
1996 2
1997 3
1998 7
1999 3
2000 13
2001 12
2002 11
2003 8
2004 11
2005 9
2006 9
2007 13
2008 12
2009 12
2010 7
2011 9
2012 10
2013 13
2014 10
2015 10
2016 4
2017 4
2018 5
2019 3
2020 8
2021 4
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

438 results
Results by year
Filters applied: . Clear all
Page 1
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody.
Espié P, He Y, Koo P, Sickert D, Dupuy C, Chokoté E, Schuler R, Mergentaler H, Ristov J, Milojevic J, Verles A, Groenewegen A, Auger A, Avrameas A, Rotte M, Colin L, Tomek CS, Hernandez-Illas M, Rush JS, Gergely P. Espié P, et al. Among authors: gergely p. Am J Transplant. 2020 Feb;20(2):463-473. doi: 10.1111/ajt.15661. Epub 2019 Dec 6. Am J Transplant. 2020. PMID: 31647605 Free article. Clinical Trial.
Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-κB, a link between inflammation and mineralization.
Éva Sikura K, Combi Z, Potor L, Szerafin T, Hendrik Z, Méhes G, Gergely P, Whiteman M, Beke L, Fürtös I, Balla G, Balla J. Éva Sikura K, et al. Among authors: gergely p. J Adv Res. 2020 Jul 21;27:165-176. doi: 10.1016/j.jare.2020.07.005. eCollection 2021 Jan. J Adv Res. 2020. PMID: 33318875 Free PMC article. Review.
Relapsing polychondritis.
Gergely P Jr, Poór G. Gergely P Jr, et al. Best Pract Res Clin Rheumatol. 2004 Oct;18(5):723-38. doi: 10.1016/j.berh.2004.05.012. Best Pract Res Clin Rheumatol. 2004. PMID: 15454129 Review.
Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z, Somogyi O, Medgyesi B, Jenei A, Szabó L, Gáspár K, Hendrik Z, Gergely P, Imre D, Póliska S, Törőcsik D, Zouboulis CC, Prens EP, Kapitány A, Szegedi A. Dajnoki Z, et al. Among authors: gergely p. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):462-471. doi: 10.1111/jdv.17779. Epub 2021 Nov 26. J Eur Acad Dermatol Venereol. 2022. PMID: 34724272 Free PMC article.
The pathogenesis of autoimmune disease.
Gergely P. Gergely P. Immunol Today. 1992 Aug;13(8):A21-3. doi: 10.1016/0167-5699(92)90062-C. Immunol Today. 1992. PMID: 1510805 Review.
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome.
Seror R, Baron G, Camus M, Cornec D, Perrodeau E, Bowman SJ, Bombardieri M, Bootsma H, Gottenberg JE, Fisher B, Hueber W, van Roon JA, Devauchelle-Pensec V, Gergely P, Mariette X, Porcher R; NECESSITY WP5 - STAR development working group; NECESSITY WP5- STAR development working group. Seror R, et al. Among authors: gergely p. Ann Rheum Dis. 2022 Jul;81(7):979-989. doi: 10.1136/annrheumdis-2021-222054. Epub 2022 Apr 7. Ann Rheum Dis. 2022. PMID: 35393271 Free PMC article.
C1-inhibitor autoantibodies in SLE.
Mészáros T, Füst G, Farkas H, Jakab L, Temesszentandrási G, Nagy G, Kiss E, Gergely P, Zeher M, Griger Z, Czirják L, Hóbor R, Haris A, Polner K, Varga L. Mészáros T, et al. Among authors: gergely p. Lupus. 2010 Apr;19(5):634-8. doi: 10.1177/0961203309357059. Epub 2010 Jan 13. Lupus. 2010. PMID: 20071476
438 results